Cannabis-related dizziness, sleepiness, anxiety, or changes in food intake can also complicate early monitoring
So I have to ask, are we simply trying to assuage our consciences
We built an entire regulatory apparatus, the FDA, clinical trials, bioavailability studies, post-market surveillance, specifically because "trust us" from a company with a financial incentive to sell you something is not a substitute for evidence
During this stage, working with your healthcare provider helps ensure your plan fits your body and your goals
A new JAMA study led by researchers from Mass Eye and Ear found that people taking semaglutide, such as Rybelsus, may be at risk for a severe eye condition known as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
This milestone offers new hope in addressing the ongoing challenge of obesity and underscores the importance of medical interventions in promoting healthier lifestyles